Table 1 Univariate analysis of demographic and clinical information on NCT of SARS-CoV-2 RNA in 32 COVID-19 patients

  <45

21 (65.6)

0.636

1.190

0.579

2.446

  >45

11 (34.4)

  Male

14 (43.8)

0.689

1.325

0.398

4.411

  Female

18 (56.3)

Smoking

4 (12.5)

0.988

0.992

0.343

2.868

  Hypertension

3 (9.4)

0.710

1.257

0.376

4.197

  Diabetes

1 (3.1)

0.110

5.750

0.671

49.244

  Coronary heart disease

1 (3.1)

0.252

3.373

0.421

26.993

  Viral hepatitis type B

2 (6.3)

0.399

0.536

0.126

2.282

  Hyperlipemia

2 (6.3)

0.199

0.550

0.221

1.370

  Cerebral hemorrhage

1 (3.1)

0.593

0.578

0.078

4.305

  Chronic bronchitis

1 (3.1)

0.110

5.750

0.671

49.244

  Depression

1 (3.1)

0.075

7.340

0.820

65.691

  Pneumonia

1 (3.1)

0.258

0.312

0.042

2.342

 The duration from disease onset to hospital

32 (100)

0.345

1.057

0.940

1.190

  Fever

24 (75.0)

0.050*

0.431

0.186

1.000

  Cough

25 (78.1)

0.564

0.779

0.334

1.818

  Expectoration

18 (56.3)

0.335

0.707

0.349

1.431

  Anhelation

11 (34.4)

0.714

0.871

0.416

1.822

  Throat discomfort

11 (34.4)

0.669

0.852

0.409

1.775

  Headache and dizziness

7 (21.9)

0.323

0.650

0.277

1.526

  Myodynia

7 (21.9)

0.123

0.491

0.199

1.213

  Osphyalgia

2 (6.3)

0.341

0.495

0.117

2.103

  Diarrhea

22 (68.8)

0.007*

0.318

0.138

0.733

  Ventosity

2 (6.3)

0.524

0.622

0.145

2.677

  Nausea

12 (37.5)

0.002*

0.262

0.112

0.613

  Vomiting

3 (9.4)

0.314

2.161

0.482

9.686

  Muscular stiffness

5 (15.6)

0.235

0.559

0.214

1.460

  Chills

2 (6.3)

0.126

3.288

0.716

15.105

  Fatigue

9 (28.1)

0.509

0.768

0.350

1.683

  Snot

3 (9.4)

0.123

0.387

0.113

1.329

  Insomnia

5 (15.6)

0.444

0.678

0.250

1.836

  Chest tightness

5 (15.6)

0.978

1.014

0.385

2.670